Guo Ji Jin Rong Bao·2025-08-12 15:08Core Viewpoint - The recent approval of insurance-funded private equity funds marks a significant advancement in China's long-term investment reform pilot, enhancing the role of insurance capital in the capital market [1][2][3] Group 1: Insurance Fund Private Equity Developments - China Pacific Insurance's subsidiary, Taiping Asset, has received approval to establish Taiping (Shenzhen) Private Securities Investment Fund Management Co., indicating a growing trend of insurance companies entering the private equity space [1][3] - A total of six insurance-related private equity fund management companies have been approved, including Guo Feng Xing Hua and Tai Kang Stable Walk, among others [3] - The first batch of pilot programs was approved in October 2023, with China Life and Xinhua Life each contributing 25 billion yuan to establish Honghu Zhiyuan (Shanghai) Private Securities Investment Fund Co. [2] Group 2: Fund Performance and Strategy - The Honghu Fund I, launched in March 2024, has successfully invested 50 billion yuan, achieving returns above the benchmark with lower risk [4] - The second phase of the Honghu Fund, with a total scale of 20 billion yuan, focuses on large listed companies in the A+H share market [4] - The Tai Kang Stable Walk Fund, which began operations in June 2023, aims for long-term stable growth through fundamental analysis of quality companies in domestic and Hong Kong markets [5] Group 3: Market Impact and Future Outlook - The introduction of long-term insurance capital is expected to enhance market stability and direct investments towards technology innovation and advanced manufacturing [5][6] - Insurance funds entering the market will increase the allocation of equity assets, helping to mitigate the pressure from low interest rates and aligning with the long-term liabilities of life insurance policies [6]